MedPath

Seoul National University Hospital

Seoul National University Hospital logo
🇰🇷South Korea
Ownership
Private
Established
2003-01-01
Employees
501
Market Cap
-
Website
https://www.snubh.org

A Randomized Trial of Udenafil Therapy in Patients With Heart Failure With Preserved Ejection Fraction [ULTIMATE-HFpEF]

Phase 3
Conditions
Diastolic Heart Failure
Interventions
First Posted Date
2012-05-15
Last Posted Date
2013-01-31
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
52
Registration Number
NCT01599117
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

🇰🇷

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of

ENhancing Maturation of Autogenous Arteriovenous Hemodialysis Access by Aggressive surveillaNCe With Duplex and Endovascular Treatment

Not Applicable
Completed
Conditions
End Stage Renal Disease
Interventions
Procedure: Duplex ultrasonography
First Posted Date
2012-05-11
Last Posted Date
2015-05-27
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
150
Registration Number
NCT01597115
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Foley Catheter Versus Dinoprostone Vaginal Insert for Induction of Labor in Parous Women at Term: A Randomized Trial

Not Applicable
Completed
Conditions
Failed Induction of Labor
Interventions
Drug: Dinoprostone 10mg
Device: Transcervical foley catheter
First Posted Date
2012-05-10
Last Posted Date
2020-03-03
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
154
Registration Number
NCT01596296
Locations
🇰🇷

Department of Obstetrics and Gynecology Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of

Lexapro®'s Efficacy After Dose Escalation in Remission Study

Phase 4
Completed
Conditions
Major Depressive Disorder
Interventions
First Posted Date
2012-05-09
Last Posted Date
2018-09-07
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
60
Registration Number
NCT01594866
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial)

Phase 4
Conditions
Critical Stenosis of Aortic Valve
Interventions
Drug: Placebo
Drug: Fimasartan
First Posted Date
2012-05-01
Last Posted Date
2012-05-02
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
100
Registration Number
NCT01589380
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

🇰🇷

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of

🇰🇷

Korea University Anam Hospital, Seoul, Korea, Republic of

and more 4 locations

Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer

Phase 2
Completed
Conditions
Hormone Receptor Positive Malignant Neoplasm of Breast
Interventions
Drug: Metformin
Drug: Placebo
First Posted Date
2012-05-01
Last Posted Date
2018-09-10
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
208
Registration Number
NCT01589367
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting

Phase 4
Completed
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2012-04-25
Last Posted Date
2012-04-25
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
148
Registration Number
NCT01584791
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Phase2, Single Group, Open Clinical Trial to Evaluate the Efficacy and Safety of Roflumilast in Symptomatic Bronchiectasis Patients

Phase 2
Conditions
Symptomatic Bronchiectasis
Interventions
First Posted Date
2012-04-19
Last Posted Date
2012-04-19
Lead Sponsor
Seoul National University Bundang Hospital
Target Recruit Count
25
Registration Number
NCT01580748
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam, Gyeongi-do, Korea, Republic of

Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine

Phase 3
Completed
Conditions
Hepatitis B
Malignancy
Interventions
First Posted Date
2012-04-18
Last Posted Date
2017-06-29
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
180
Registration Number
NCT01580202
Locations
🇰🇷

National Cancer Center, Korea, Goyang, Gyeonggi, Korea, Republic of

🇰🇷

Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of

🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

and more 2 locations

The Effect of Dexmedetomidine on Emergence Agitation in Children Undergoing a Surgery Under Desflurane Anesthesia

Phase 4
Conditions
Psychomotor Agitation
Interventions
Drug: Dexmedetomidine
Drug: 0.9% Normal Saline
First Posted Date
2012-04-16
Last Posted Date
2012-04-16
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
116
Registration Number
NCT01578161
Locations
🇰🇷

Department of Anesthesiology and Pain Medicine, SEOUL NATIONAL UNIVERSITY BUNDANG HOSPITAL, SungNam-si, Kyonggi do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath